Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
162 Leser
Artikel bewerten:
(0)

mHealth Market to Reach $230.41 Bn, Globally, by 2027 at 22.3% CAGR: Allied Market Research

- Increase in prevalence of lifestyle disorders, integration of portable healthcare devices and wireless technologies, and favorable government initiatives drive the growth of the global mHealth market

PORTLAND, Oregon, April 21, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, "mHealth Market by Type (mHealth Devices and mHealth Services), Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers, and Content Players), and Application (Cardiovascular Diseases, Diabetes, Respiratory diseases, Neurological Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027." According to the report, the global mHealth market generated $46.04 billion in 2019, and is estimated to garner $230.41 billion by 2027, growing at a CAGR of 22.3% from 2020 to 2027.

Allied Market Research

Drivers, restrains, and opportunities

Increase in prevalence of lifestyle disorders, integration of portable healthcare devices and wireless technologies, and favorable government initiatives drive the growth of the global mHealth market. However, unavailability of standard reimbursement policies along with lack of technological awareness regarding geriatric population hinder the market growth. On the other hand, potential for growth in untapped geographies create new opportunities in the coming years.

Request Sample Report at:https://www.alliedmarketresearch.com/request-sample/77

The mHealth services segment to maintain its highest contribution by 2026

Based on type, the mHealth services segment accounted for the highest market share in 2019, contributing to more than three-fifths of the global mHealth market, and is estimated to maintain its highest contribution throughout the forecast period. This is due to technological advancements in the healthcare sector and prevalence of chronic diseases. However, the mHealth devices segment is expected to witness the largest CAGR of 23.8% from 2020 to 2027. This is attributed to increase in awareness regarding early detection and monitoring of chronic diseases including hypertension and diabetes.

The cardiovascular diseases segment to continue its lead status during the forecast period

Based on application, the cardiovascular diseases segment accounted for more than half of the global mHealth market in 2019, and is expected to continue its lead status throughout the forecast period. This is due to surge in prevalence of cardiovascular diseases worldwide and increase in adoption of mHealth services to manage such medical conditions. However, the neurological diseases segment would register the fastest CAGR of 23.9% from 2020 to 2027, owing to increased focus of key players on the launch of novel and advanced mHealth devices to manage neurological conditions.

North America to maintain its dominant position throughout the forecast period

Based on region, North America held nearly two-fifths of the global mHealth market in 2019, and is estimated to maintain its dominant position throughout the forecast period. This is due to rise in awareness about the need to frequent monitoring of symptoms of chronic diseases to gain optimum treatment outcomes. However, Asia-Pacific is expected to contribute to the fastest CAGR of 25.7% from 2020 to 2027, owing to surge in mHealth application with huge population suffering from chronic diseases such as diabetes and hypertension.

For Purchase Enquiry at:https://www.alliedmarketresearch.com/purchase-enquiry/77

Leading Market Players

  • Bayer Healthcare
  • Boston Scientific Corporation
  • Dexcom, Inc.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic plc
  • Omron Corporation
  • Samsung Group
  • Sanofi

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

Teleradiology Market - Global Opportunity Analysis and Industry Forecast, 2020-2027

Vascular Guidewires Market- Global Opportunity Analysis and Industry Forecast, 2020-2027

Next Generation Sequencing (NGS) Market - Global Opportunity Analysis and Industry Forecast, 2020-2027

Medical Spa Market - Global Opportunity Analysis and Industry Forecast, 2020-2027

Migraine Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020-2027

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

© 2020 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.